-- Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Increases in neutralizing antibodies of approximately 6-8 fold for RSV,...
Hence then, the article about clover announces positive phase i clinical data for rsv hmpv piv3 combination vaccines and for rsv re vaccination in older adults was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults )
Also on site :
- Sheikh Sabri: Israeli enemy seeks to change reality of al-Aqsa Mosque as prelude to seizing control of it
- At 61, this major insurance CEO works out 6 days a week with his 23-year-old son—he picks his brain for a Gen Z perspective while lifting weights
- Not all degrees are a waste of time: MBA graduates from Harvard, MIT, and Wharton are making over $245,000 just three years after graduating